Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor PCC

被引：0
|
作者：
Zahir, Hamim [1 ]
Vandell, Alexander [2 ]
Desai, Madhuri [1 ]
Maa, Jen-Fu [3 ]
Dishy, Victor [4 ]
Lomelli, Barbara [5 ]
Feussner, Annette [6 ]
Feng, Wenquin [7 ]
He, Ling [8 ]
Grosso, Michael A. [9 ]
Lanz, Hans J. [9 ]
Brown, Karen S. [1 ]
机构：
[1] Daiichi Sankyo Pharma Dev, Translat Med & Clin Pharmacol, Edison, NJ USA
[2] Daiichi Sankyo Pharma Dev, Clin Pharmacogen, Edison, NJ USA
[3] Daiichi Sankyo Inc, Biostat, Parsippany, NJ USA
[4] Daiichi Sankyo Pharma Dev, Expt Med, Edison, NJ USA
[5] Quintiles Inc, Early Clin Dev, Overland, KS USA
[6] CSL Behring GmbH, Preclin Rsch & Dev, Marburg, Germany
[7] Daiichi Sankyo Pharma Dev, Clin Biomarker Anal, Edison, NJ USA
[8] Daiichi Sankyo Pharma Dev, Clin Bioanal, Edison, NJ USA
[9] Daiichi Sankyo Pharma Dev, Clin Dev, Edison, NJ USA
来源：
CIRCULATION | 2014年 / 130卷 / 23期
关键词：
Anticoagulants; Factor xa; Dose-response relation; drug; Anticoagulation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2116 / 2116
页数：1
相关论文
共 35 条
  • [1] Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate
    Zahir, Hamim
    Brown, Karen S.
    Vandell, Alexander G.
    Desai, Madhuri
    Maa, Jen-Fue
    Dishy, Victor
    Lomeli, Barbara
    Feussner, Annette
    Feng, Wenqin
    He, Ling
    Grosso, Michael A.
    Lanz, Hans J.
    Antman, Elliott M.
    CIRCULATION, 2015, 131 (01) : 82 - +
  • [2] Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding
    Stewart, William S.
    Pettit, Herbert
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (08) : 1251 - 1254
  • [3] Utilization of 4-Factor Prothrombin Complex Concentrate for Reversal of Oral Factor Xa Inhibitor-Associated Acute Major Bleeding: A Case Series
    Reynolds, Tessa R.
    Gilbert, Brian W.
    Hall, Katherine M.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (05) : 755 - 760
  • [4] Evaluation of a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal
    McMahon, Clare
    Halfpap, Joe
    Zhao, Qianqian
    Bienvenida, Ana
    Rose, Anne E.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (10) : 1230 - 1235
  • [5] Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
    Allison, Teresa A.
    Lin, Pei Jen
    Gass, Jennifer A.
    Chong, Kenneth
    Prater, Samuel J.
    Escobar, Miguel A.
    Hartman, Heather D.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (09) : 903 - 908
  • [6] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Paige Garber Bradshaw
    Shaun Keegan
    Madeline Foertsch
    George L. Yang
    Laura B. Ngwenya
    Vasisht Srinivasan
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 295 - 300
  • [7] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Bradshaw, Paige Garber
    Keegan, Shaun
    Foertsch, Madeline
    Yang, George L.
    Ngwenya, Laura B.
    Srinivasan, Vasisht
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 295 - 300
  • [8] Effectiveness and Safety of 4-factor Prothrombin Complex Concentrate (4PCC) in Neonates With Intractable Bleeding or Severe Coagulation Disturbances: A Retrospective Study of 37 Cases
    Mitsiakos, Georgios
    Karametou, Margarita
    Gkampeta, Anastasia
    Karali, Crysa
    Papathanasiou, Aimilia Eirini
    Papacharalambous, Efthimia
    Babacheva, Evgenyia
    Papadakis, Emmanouil
    Yupsani, Anastasia
    Chatziioannidis, Ilias
    Soubasi, Vassiliki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) : E135 - E140
  • [9] Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents
    Fukuda, Toshio
    Honda, Yuko
    Kamisato, Chikako
    Morishima, Yoshiyuki
    Shibano, Toshiro
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (02) : 253 - 259
  • [10] Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
    Abdalla A. Ammar
    Mahmoud A. Ammar
    Kent A. Owusu
    Stacy C. Brown
    Firas Kaddouh
    Aladine A. Elsamadicy
    Julián N. Acosta
    Guido J. Falcone
    Neurocritical Care, 2021, 35 : 255 - 261
1234